Literature DB >> 3312689

Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals.

A R Rhodes1, M A Weinstock, T B Fitzpatrick, M C Mihm, A J Sober.   

Abstract

Cutaneous melanoma is rapidly becoming a potentially curable cancer if it is detected and properly treated in an early phase of development. Unlike other cancers, which are usually hidden from detection until they are relatively large or metastatic disease has occurred, cutaneous melanoma is readily detectable simply by examining the skin. Information is now available that will be useful in selecting individuals at greatest risk. The most important melanoma risk factors (in decreasing order of importance) for a given individual are as follows: a persistently changed or changing mole, adulthood, irregular varieties of pigmented lesions (including dysplastic moles and lentigo maligna), a congenital mole, Caucasian race, a previous cutaneous melanoma, a family history of cutaneous melanoma, immunosuppression, sun sensitivity, and excessive sun exposure. Selective screening and appropriate treatment of individuals who have these risk factors may reduce the morbidity and mortality of cutaneous melanoma.

Entities:  

Mesh:

Year:  1987        PMID: 3312689

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  31 in total

1.  Melanoma: A new strategy to reduce morbidity and mortality.

Authors:  Cameron Williams; Christopher Quirk; Anna Quirk
Journal:  Australas Med J       Date:  2014-07-31

2.  Tailored versus generic interventions for skin cancer risk reduction for family members of melanoma patients.

Authors:  Sharon Manne; Paul B Jacobsen; Michael E Ming; Gary Winkel; Sophie Dessureault; Stuart R Lessin
Journal:  Health Psychol       Date:  2010-11       Impact factor: 4.267

Review 3.  Melanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?

Authors:  Nayoung Lee; Steven R Barthel; Tobias Schatton
Journal:  Lab Invest       Date:  2013-10-14       Impact factor: 5.662

4.  How does pheomelanin synthesis contribute to melanomagenesis?: Two distinct mechanisms could explain the carcinogenicity of pheomelanin synthesis.

Authors:  Ann M Morgan; Jennifer Lo; David E Fisher
Journal:  Bioessays       Date:  2013-05-07       Impact factor: 4.345

5.  Sun protection practices and sun exposure among children with a parental history of melanoma.

Authors:  Beth A Glenn; Tiffany Lin; L Cindy Chang; Ashley Okada; Weng Kee Wong; Karen Glanz; Roshan Bastani
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-01       Impact factor: 4.254

6.  Effectiveness of a skin cancer control educational intervention for internal medicine housestaff and attending physicians.

Authors:  N C Dolan; J S Ng; G J Martin; J K Robinson; A W Rademaker
Journal:  J Gen Intern Med       Date:  1997-09       Impact factor: 5.128

7.  Melanoma: Molecular Pathogenesis and Therapeutic Management.

Authors:  Yuxin Liu; M Saeed Sheikh
Journal:  Mol Cell Pharmacol       Date:  2014

8.  Giant congenital melanocytic nevi: a case report.

Authors:  Sudhanshu Ku Das; Amarendra M; Monalisa Subudhi
Journal:  J Clin Diagn Res       Date:  2012-11-01

9.  Treatment and outcomes of melanoma in acral location in Korean patients.

Authors:  Mi Ryung Roh; Jihyun Kim; Kee Yang Chung
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759

10.  Effects of a short messaging service-based skin cancer prevention campaign in adolescents.

Authors:  Melanie D Hingle; Aimee L Snyder; Naja E McKenzie; Cynthia A Thomson; Robert A Logan; Eden A Ellison; Stephanie M Koch; Robin B Harris
Journal:  Am J Prev Med       Date:  2014-07-19       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.